Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for ...
Advanced BioMedical Technologies reported revenue of $123,587 for fiscal year 2020, up 960.2% from fiscal year 2019, and net income of -$672,000. In Q3 2021 (the quarter ended July 31, 2021) revenue was $180, down 81.3% from a year before. Its market capitalization was $35,452 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended October 31, 2020; market data as of October 8, 2026.
No profile data available.